Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher I Li

Showing results (91-100 of 276) with videos related to

Pageof 28
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2019
Relationship between Diabetes and Diabetes Medications and Risk of Different Molecular Subtypes of Breast CancerHongjie Chen, Linda S Cook, Mei-Tzu C Tang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2008
Reproductive factors, age at maximum height, and risk of three histologic types of breast cancerElisabeth F Beaber, Victoria L Holt, Kathleen E Malone, et al.
Breast Cancer Research and Treatment|December 11, 2012
Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of ageChristopher I Li, Elisabeth F Beaber, Mei-Tzu Chen Tang, et al.
Breast Cancer Research and Treatment|April 22, 2014
Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of ageChristopher I Li, Janet R Daling, Kara L Haugen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2003
The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of ageChristopher I Li, Kathleen E Malone, Peggy L Porter, et al.
Cancer Causes & Control : CCC|December 11, 2012
Use of antihypertensive medications and breast cancer riskBabette S Saltzman, Noel S Weiss, Weiva Sieh, et al.
Cancer Research|August 3, 2014
Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of ageElisabeth F Beaber, Diana S M Buist, William E Barlow, et al.
Journal of the National Cancer Institute|May 6, 2024
Executing plans to enhance diversity across cancer centers in the United States: opportunities and challengesChristopher I Li, Sherise Chantell Rogers, Carol J Bult, et al.
Gynecologic Oncology|November 3, 2015
Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumorsMatthew F Buas, Haiwei Gu, Danijel Djukovic, et al.
International Journal of Cancer|October 2, 2003
Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of ageChristopher I Li, Kathleen E Malone, Peggy L Porter, et al.
Pageof 28

Showing results (91-100 of 276) with videos related to

Sort By:
Pageof 28
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2019
Relationship between Diabetes and Diabetes Medications and Risk of Different Molecular Subtypes of Breast CancerHongjie Chen, Linda S Cook, Mei-Tzu C Tang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 10, 2008
Reproductive factors, age at maximum height, and risk of three histologic types of breast cancerElisabeth F Beaber, Victoria L Holt, Kathleen E Malone, et al.
Breast Cancer Research and Treatment|December 11, 2012
Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of ageChristopher I Li, Elisabeth F Beaber, Mei-Tzu Chen Tang, et al.
Breast Cancer Research and Treatment|April 22, 2014
Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of ageChristopher I Li, Janet R Daling, Kara L Haugen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2003
The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of ageChristopher I Li, Kathleen E Malone, Peggy L Porter, et al.
Cancer Causes & Control : CCC|December 11, 2012
Use of antihypertensive medications and breast cancer riskBabette S Saltzman, Noel S Weiss, Weiva Sieh, et al.
Cancer Research|August 3, 2014
Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of ageElisabeth F Beaber, Diana S M Buist, William E Barlow, et al.
Journal of the National Cancer Institute|May 6, 2024
Executing plans to enhance diversity across cancer centers in the United States: opportunities and challengesChristopher I Li, Sherise Chantell Rogers, Carol J Bult, et al.
Gynecologic Oncology|November 3, 2015
Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumorsMatthew F Buas, Haiwei Gu, Danijel Djukovic, et al.
International Journal of Cancer|October 2, 2003
Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of ageChristopher I Li, Kathleen E Malone, Peggy L Porter, et al.
Pageof 28